# Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries

> **NCT01258972** · NA · COMPLETED · sponsor: **Tryton Medical, Inc.** · enrollment: 133 (actual)

## Conditions studied

- Coronary Atherosclerosis of Native Coronary Artery
- Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery

## Interventions

- **DEVICE:** Tryton Side Branch Stent with main branch DES
- **DEVICE:** POBA

## Key facts

- **NCT ID:** NCT01258972
- **Lead sponsor:** Tryton Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-11
- **Final completion:** 2016-10
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258972, "Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01258972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*